Nocturnal Non-Invasive Ventilation for Chronic Obstructive Pulmonary Disease: A Final Breakthrough? - European Medical Journal
×

Browse

Nocturnal Non-Invasive Ventilation for Chronic Obstructive Pulmonary Disease: A Final Breakthrough?

| Download as | PDF
Chairpeople:
Wolfram Windisch1
Speakers:
Jean-Louis Pepin,,2 Thomas Köhnlein,3 Michael Dreher4
Disclosure:

Prof Windisch has received open research grants for his hospital and personal speaking fees from companies dealing with mechanical ventilation. Dr Pepin received personal fees from ResMed, Philips, Fisher & Paykel for lectures during congress symposia, and unrestricted grants from ResMed, Philips, and AGIRadom for conducting clinical studies. Dr Köhnlein has received grants and lecture fees from Deutsche Lungenstiftung, ResMed, Tyco, Weinmann, and Heinen und Löwenstein. Dr Dreher receives an open research grant from ResMed, and has received speaking fees and/or fees for advisory boards from: Weinmann, Respironics, Vivisol, Linde, ResMed, Breas, Novartis, Boehringer, Almirall, Actelion, and Chiesi.

Acknowledgements:

Writing assistance was provided by Dr Ewen Legg of apothecom scopemedical.

Support:

Medical writing assistance was funded by ResMed. The views and opinions expressed are those of the authors as expressed during the symposium and not necessarily of ResMed.

Citation
EMJ Respir. ;2:41-48.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Meeting Summary

Prof Windisch opened the symposium on the efficacy of non-invasive ventilation (NIV) in the treatment of chronic obstructive pulmonary disease (COPD). Dr Jean-Louis Pepin summarised the evidence for efficacy of NIV in subgroups of COPD patients. Dr Thomas Köhnlein focused on a recently-published randomised trial showing a major reduction in mortality following NIV aimed at a marked reduction in carbon dioxide pressure (PaCO2), while Dr Michael Dreher illustrated the place of NIV in patients with recent exacerbations.

Receive our free quarterly newsletters and your choice of journal publication alerts, straight to your inbox.

Join our mailing list

Please view the full content in the pdf above.